Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- The potential next pathway to target in CVD prevention: ‘Common’ elevated Lp(a) Regina Schaffer
-
- Addressing glucocorticoid withdrawal syndrome in treatment of Cushing’s syndrome Richard J. Auchus, MD, PhD; Xin He, MD, MBA
- Coordinated care can improve prescribing practices of recommended diabetes, CVD therapies Katie Kalvaitis
- DEA temporarily extends telehealth prescribing flexibility for controlled substances Andrew (Drew) Rhoades
- Exposure to EDCs may negatively affect thyroid function, but more research needed Michael Monostra
- FDA grants orphan drug designation for rare pediatric skeletal disease therapy
- High post-dexamethasone cortisol levels linked to lower eGFR independent of CV factors Erin T. Welsh, MA
- Hispanic and Asian adults with thyroid cancer have lower risk for death than white adults Michael Monostra
- Most adults with diabetes report CGM disruptions due to device problems, medical care Michael Monostra
-
- PTH therapy cuts need for calcium, vitamin D supplements for most with hypoparathyroidism Michael Monostra
- VIDEO: Screening a key part of treatment for primary hyperaldosteronism Michael Monostra; Jonathan D. Leffert, MD, FACP, FACE, ECNU; Richard J. Auchus, MD, PhD
- FDA approves fezolinetant to treat hot flashes caused by menopause
- AI, machine learning may aid in PCOS detection, reducing undiagnosed burden Erin T. Welsh, MA
- Personalized approach emphasized in AACE consensus statement for treating type 2 diabetes Michael Monostra
- VIDEO: Address weight bias as a complication of obesity Michael Monostra